Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Treace Medical Concepts (TMCI) Assets Average (2021 - 2025)

Treace Medical Concepts (TMCI) has disclosed Assets Average for 5 consecutive years, with $193.6 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Assets Average fell 9.96% year-over-year to $193.6 million, compared with a TTM value of $193.6 million through Dec 2025, down 9.96%, and an annual FY2025 reading of $203.8 million, down 13.08% over the prior year.
  • Assets Average was $193.6 million for Q4 2025 at Treace Medical Concepts, down from $201.5 million in the prior quarter.
  • Across five years, Assets Average topped out at $249.4 million in Q2 2023 and bottomed at $39.6 million in Q1 2021.
  • Average Assets Average over 5 years is $184.7 million, with a median of $202.8 million recorded in 2023.
  • The sharpest move saw Assets Average soared 262.84% in 2022, then decreased 14.49% in 2025.
  • Year by year, Assets Average stood at $139.2 million in 2021, then grew by 13.31% to $157.7 million in 2022, then skyrocketed by 56.04% to $246.1 million in 2023, then decreased by 12.65% to $215.0 million in 2024, then decreased by 9.96% to $193.6 million in 2025.
  • Business Quant data shows Assets Average for TMCI at $193.6 million in Q4 2025, $201.5 million in Q3 2025, and $206.1 million in Q2 2025.